{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:40:02Z","timestamp":1787060402609,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012737","name":"Department of Health and Human Services, State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001215","name":"La Trobe University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001215","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ab.2020.113877","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T11:10:29Z","timestamp":1596021029000},"page":"113877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Generation of reporter cell lines for factors inducing muscle wasting in cancer cachexia"],"prefix":"10.1016","volume":"606","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4142-6190","authenticated-orcid":false,"given":"Zhipeng","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irvin","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1435-9746","authenticated-orcid":false,"given":"Jason","family":"Glab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamsa","family":"Puthalakath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6174-3797","authenticated-orcid":false,"given":"Laura D.","family":"Osellame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3124-1363","authenticated-orcid":false,"given":"Nick J.","family":"Hoogenraad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ab.2020.113877_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ab.2020.113877_bib2","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrc927","article-title":"Cachexia in cancer patients","volume":"2","author":"Tisdale","year":"2002","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ab.2020.113877_bib3","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.cell.2015.08.031","article-title":"Targeting of Fn14 prevents cancer-induced cachexia and prolongs survival","volume":"162","author":"Johnston","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ab.2020.113877_bib4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1158\/1541-7786.MCR-08-0005","article-title":"The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity","volume":"6","author":"Willis","year":"2008","journal-title":"Mol. Canc. Res. : MCR"},{"key":"10.1016\/j.ab.2020.113877_bib5","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1158\/0008-5472.CAN-13-3233","article-title":"AR-regulated TWEAK-FN14 pathway promotes prostate cancer bone metastasis","volume":"74","author":"Yin","year":"2014","journal-title":"Canc. Res."},{"key":"10.1016\/j.ab.2020.113877_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2011.01054.x","article-title":"TWEAK\/Fn14 pathway: an immunological switch for shaping tissue responses","volume":"244","author":"Burkly","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ab.2020.113877_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/165974","article-title":"Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view","volume":"2013","author":"Schulte","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ab.2020.113877_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.physbeh.2010.11.037","article-title":"The effect of TNF\u03b1 on food intake and central insulin sensitivity in rats","volume":"103","author":"de Kloet","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ab.2020.113877_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","article-title":"TNF-\u03b1 and cancer cachexia: molecular insights and clinical implications","volume":"170","author":"Patel","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.ab.2020.113877_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.febslet.2007.11.051","article-title":"TNF-alpha and adipocyte biology","volume":"582","author":"Cawthorn","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ab.2020.113877_bib11","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1096\/fj.13-245894","article-title":"Elevated expression of activins promotes muscle wasting and cachexia","volume":"28","author":"Chen","year":"2014","journal-title":"Faseb. J."},{"key":"10.1016\/j.ab.2020.113877_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ab.2020.113877_bib13","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1158\/0008-5472.CAN-15-1740","article-title":"Detection of pancreatic cancer-induced cachexia using a fluorescent myoblast reporter system and analysis of metabolite abundance","volume":"76","author":"Winnard","year":"2016","journal-title":"Canc. Res."},{"key":"10.1016\/j.ab.2020.113877_bib14","article-title":"Characterization of an acute muscle contraction model using cultured C2C12 myotubes","volume":"7","author":"Manabe","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ab.2020.113877_bib15","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1113\/EP086860","article-title":"Regulation of muscle protein synthesis in an in vitro cell model using ex vivo human serum","volume":"103","author":"Carson","year":"2018","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ab.2020.113877_bib16","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.3892\/or.2015.3845","article-title":"Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study","volume":"33","author":"Yuan","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ab.2020.113877_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semcancer.2016.01.002","article-title":"F-BOX proteins in cancer cachexia and muscle wasting: emerging regulators and therapeutic opportunities","volume":"36","author":"Sukari","year":"2016","journal-title":"Semin. Canc. Biol."},{"key":"10.1016\/j.ab.2020.113877_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059726","article-title":"Ppar\u03b2\/\u03b4 regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting","volume":"8","author":"Castillero","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ab.2020.113877_bib19","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.27.1_supplement.549.1","article-title":"Activation of the glucocorticoid receptor by dexamethasone enhances BHV-1 productive infection","volume":"27","author":"Ahlers","year":"2013","journal-title":"Faseb. J."},{"key":"10.1016\/j.ab.2020.113877_bib20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccr.2005.10.004","article-title":"Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia","volume":"8","author":"Acharyya","year":"2005","journal-title":"Canc. Cell"},{"key":"10.1016\/j.ab.2020.113877_bib21","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1038\/emboj.2011.292","article-title":"C\/EBP\u03b2 mediates tumour-induced ubiquitin ligase atrogin1\/MAFbx upregulation and muscle wasting","volume":"30","author":"Zhang","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.ab.2020.113877_bib22","doi-asserted-by":"crossref","first-page":"E785","DOI":"10.1152\/ajpendo.00646.2007","article-title":"The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene","volume":"295","author":"Waddell","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.ab.2020.113877_bib23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ab.2020.113877_bib24","doi-asserted-by":"crossref","first-page":"18613","DOI":"10.1074\/jbc.M701983200","article-title":"Transcriptional regulation of Cidea, mitochondrial cell death-inducing DNA fragmentation factor alpha-like effector A, in mouse liver by peroxisome proliferator-activated receptor alpha and gamma","volume":"282","author":"Viswakarma","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2020.113877_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1152\/physiolgenomics.00011.2002","article-title":"Gene expression changes during mouse skeletal myoblast differentiation revealed by transcriptional profiling","volume":"10","author":"Moran","year":"2002","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.ab.2020.113877_bib26","article-title":"Physiological culture conditions alter myotube morphology and responses to atrophy treatments: implications for in vitro research on muscle wasting","volume":"6","author":"Archer-Lahlou","year":"2018","journal-title":"Phys. Rep."},{"key":"10.1016\/j.ab.2020.113877_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-2478(85)90165-8","article-title":"Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumor necrosis factor)","volume":"11","author":"Cerami","year":"1985","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ab.2020.113877_bib28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ijc.2910610416","article-title":"Establishment and characterization of cachexia-inducing and -non-inducing clones of murine colon 26 carcinoma","volume":"61","author":"Fujimoto-Ouchi","year":"1995","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ab.2020.113877_bib29","doi-asserted-by":"crossref","first-page":"40235","DOI":"10.1074\/jbc.M004356200","article-title":"Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation","volume":"275","author":"Thomas","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2020.113877_bib30","first-page":"534","article-title":"Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice","volume":"10","author":"Coerver","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ab.2020.113877_bib31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.15252\/emmm.201607231","article-title":"Supraphysiological levels of GDF11 induce striated muscle atrophy","volume":"9","author":"Hammers","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ab.2020.113877_bib32","series-title":"Animal Models in Cancer Drug Discovery","first-page":"59","article-title":"Chapter 3 - animal models of cancer-associated cachexia","author":"Shukla","year":"2019"},{"key":"10.1016\/j.ab.2020.113877_bib33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2141\/jpsa.0180092","article-title":"Myostatin increases Smad2 phosphorylation and atrogin-1 expression in chick embryonic myotubes","volume":"56","author":"Saneyasu","year":"2019","journal-title":"J. Poultry Sci."},{"key":"10.1016\/j.ab.2020.113877_bib34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bbrc.2017.10.040","article-title":"Myostatin inhibits eEF2K-eEF2 by regulating AMPK to suppress protein synthesis","volume":"494","author":"Deng","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ab.2020.113877_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00401","article-title":"The mechanical stimulation of myotubes counteracts the effects of tumor-derived factors through the modulation of the activin\/follistatin ratio","volume":"10","author":"Baccam","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ab.2020.113877_bib36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jcsm.12145","article-title":"Activin A induces skeletal muscle catabolism via p38\u03b2 mitogen-activated protein kinase","volume":"8","author":"Ding","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ab.2020.113877_bib37","doi-asserted-by":"crossref","DOI":"10.1186\/2044-5040-2-2","article-title":"TNF-\u03b1- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism","volume":"2","author":"De Larichaudy","year":"2012","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.ab.2020.113877_bib38","doi-asserted-by":"crossref","first-page":"R1165","DOI":"10.1152\/ajpregu.2000.279.4.R1165","article-title":"NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes","volume":"279","author":"Li","year":"2000","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ab.2020.113877_bib39","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/MCB.01307-13","article-title":"An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy","volume":"34","author":"Lach-Trifilieff","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ab.2020.113877_bib40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.fob.2015.08.011","article-title":"FHL1 activates myostatin signalling in skeletal muscle and promotes atrophy","volume":"5","author":"Lee","year":"2015","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.ab.2020.113877_bib41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/thorax.55.7.603","article-title":"Molecular mechanisms of glucocorticoid action: what is important?","volume":"55","author":"Newton","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.ab.2020.113877_bib42","doi-asserted-by":"crossref","first-page":"E785","DOI":"10.1152\/ajpendo.00646.2007","article-title":"The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene","volume":"295","author":"Waddell","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.ab.2020.113877_bib43","doi-asserted-by":"crossref","first-page":"E1128","DOI":"10.1152\/ajpendo.2001.281.6.E1128","article-title":"Characterization of 5\u2032-regulatory region of human myostatin gene: regulation by dexamethasone in vitro","volume":"281","author":"Ma","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.ab.2020.113877_bib44","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbrc.2014.06.080","article-title":"Identification of functional glucocorticoid response elements in the mouse FoxO1 promoter","volume":"450","author":"Qin","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ab.2020.113877_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042166","article-title":"FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop","volume":"7","author":"L\u00fctzner","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ab.2020.113877_bib46","doi-asserted-by":"crossref","first-page":"E495","DOI":"10.1152\/ajpendo.00389.2016","article-title":"Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome","volume":"312","author":"Kang","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.ab.2020.113877_bib47","doi-asserted-by":"crossref","first-page":"C1258","DOI":"10.1152\/ajpcell.00105.2009","article-title":"Myostatin reduces Akt\/TORC1\/p70S6K signaling, inhibiting myoblast differentiation and myotube size","volume":"296","author":"Trendelenburg","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ab.2020.113877_bib48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/SPC.0b013e32834bddf9","article-title":"Targeting the myostatin signaling pathway to treat muscle wasting diseases","volume":"5","author":"Han","year":"2011","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.ab.2020.113877_bib49","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1074\/jbc.M411346200","article-title":"Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase","volume":"280","author":"Tintignac","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2020.113877_bib50","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/emboj.2008.52","article-title":"The initiation factor eIF3-f is a major target for atrogin1\/MAFbx function in skeletal muscle atrophy","volume":"27","author":"Lagirand-Cantaloube","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.ab.2020.113877_bib51","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/ncponc0112","article-title":"Therapy insight: cancer anorexia-cachexia syndrome--when all you can eat is yourself","volume":"2","author":"Laviano","year":"2005","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.ab.2020.113877_bib52","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Primers"}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269720304097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269720304097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T21:29:42Z","timestamp":1757712582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269720304097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":52,"alternative-id":["S0003269720304097"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2020.113877","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of reporter cell lines for factors inducing muscle wasting in cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2020.113877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113877"}}